VR Logo

Mahavir Advanced Remedies Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

48 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2014 download pdf full AR
2013 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2012 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2011 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2010 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2009 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
1998 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1992

Chairman: BVS Koteswara Rao

Managing Director: BVS Koteswara Rao

Group: --

Listing:

Headquarters: --

Website:--

Key Facts

Market cap: R --

Revenue (TTM): R --

Earnings (TTM): R --

: R --

: R --

Promoters' ownership: --

Liquidity:

52 Week range: R -- - --

Face value: R--

Shares outstanding: --

5 Years Aggregate:

  • CFO: -7.69 Cr
  • EBITDA: -0.58 Cr
  • Net Profit: -0.44 Cr

Stock Performance

Time Period Mahavir Advanced Remedies S&P BSE Healthcare S&P BSE Small Cap
YTD--19.3263.35
1 month---2.575.56
3 months---1.8312.06
1 Year--31.0499.06
3 Years--21.1328.01
5 Years--9.5717.22
10 Years--15.8315.65
As on 19-Oct-2021
Year Mahavir Advanced Remedies S&P BSE Small Cap S&P BSE Healthcare
2014167.3869.2447.43